-
NASCAR and Its Race Teams Fight Over the Sport’s Future
Team owners said they needed to share in racing’s financial success, putting them at odds with the privately held business that runs the sport.
-
Republicans Call on NPR’s Chief, Katherine Maher, to Testify on Bias
Katherine Maher, the radio network’s new chief executive, has been in the spotlight since an editor published an essay accusing the organization of leftward-leaning bias.
-
Joe Biden, the Ultimate D.C. Veteran, Has Never Seen a Campaign Like This
In 30 years of Senate bids, Mr. Biden was such a formidable incumbent that he did not face a serious threat to his return to office. His last re-election is shaping up to be something different: a fight.
-
A Mysterious Flier, a Tiny Charity and a Disinformation Campaign at the Border
A flier urging migrants to vote for President Biden rocketed around right-wing social media. But was it authentic?
-
Unconventional Love: Exploring the Rise of Open Relationships in Modern Society
Love has always been a topic of fascination and exploration for humans. From classic tales of romance to modern-day dating apps, we are constantly searching for the perfect love story. But in recent years, a new type of love has emerged, one that challenges traditional notions of monogamy and commitment. Open relationships, once considered taboo,…
-
That’s All Capital Gain Right? Income Taxes and Intellectual Property Monetization
Intellectual property (“IP”) is typically monetized either by sale or (royalty generating) license agreements. The Code often allows sales to be taxed at preferential capital gains rates while simple royalties are ordinary income. At present the maximum capital gain versus ordinary income rate differential for non-corporate taxpayers – without more – is seventeen percent which…
-
UCB, Inc. v. Mylan Techs. Inc. – Neupro® (Rotigotine)
Case Name: UCB, Inc. v. Mylan Techs. Inc., Civ. No. 22-cv-216 (D. Vt. Mar. 8, 2024) (Reiss, J.) – Drug Product and Patent(s)-in-Suit: Neupro® (rotigotine); U.S. Patents Nos. 8,246,979 (“the ’979 patent”) and 8,246,980 (“the ’980 patent”)….By: Robins Kaplan LLP
-
Account Takeover and Business Email Compromise Fraud: Legally Puzzling Payments Problems
In a series of three articles, we will address the ascendency of account takeover (“ATO”) and business email compromise (“BEC”) fraud — the unfortunate occurrence where a payor or intended payee’s account is compromised, leading to the misdirection of payments to a threat actor….By: Arnall Golden Gregory LLP
-
Artificial Intelligence Executive Order WHD and OFCCP Guidance Issued
On April 29, 2024, the White House released a statement entitled, “Biden-Harris Administration Announces Key AI Actions 180 Days Following President Biden’s Landmark Executive Order.” A few hours later, the U.S. Department of Labor’s (DOL) Wage and Hour Division (WHD) and Office of Federal Contract Compliance Programs (OFCCP) released guidance documents about the use of…
-
HHS Finalizes Antidiscrimination Rules On Patient Care Decision Tools, Including AI
Last week, the Department of Health and Human Services (HHS) finalized antidiscrimination regulations implementing Section 1557 of the Affordable Care Act (ACA Section 1557). The final rule expands upon the proposed rule’s prohibition of discrimination through the use of clinical algorithms….By: Manatt, Phelps & Phillips, LLP